PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.\', \'Institute of Epidemiology and Public Health, University College London, London, United Kingdom.\', \'Instituto Nacional de Psiquiatría, Mexico City, Mexico.\', \'Clinical and Translational Oncology Group, Clínica del Country, Bogota, Colombia.\', \'Center for Thoracic Oncology, Tisch Cancer Institute, Mount Sinai Medical System & Icahn School of Medicine, Mount Sinai, New York, New York, USA.\', \'Instituto Nacional de Ciencias Médicas y Nutrición y Salvador Zubirán (INCMNSZ), Mexico City, Mexico.\', \'Instituto Nacional de Enfermedades Respiratorias (INER), Mexico City, Mexico.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/onco.13962
?:doi
?:hasPublicationType
?:journal
  • The oncologist
is ?:pmid of
?:pmid
?:pmid
  • 34498780
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic Malignancies.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all